Company Information & Drug Savings for Bristol-Myers Squibb Medications

Bristol-Myers Squibb (BMS) is a global biopharmaceutical company transforming patients’ lives through science. BMS leads in oncology, hematology, immunology, cardiovascular, and fibrotic diseases. Key products include Opdivo (nivolumab) and Yervoy (ipilimumab) for cancer immunotherapy, Revlimid (lenalidomide) and Pomalyst for multiple myeloma, Eliquis (apixaban) for blood clots and stroke prevention, and Orencia for rheumatoid arthritis. BMS’s innovative pipeline continues advancing breakthrough treatments for serious diseases.

Bristol-Myers Squibb

How to Contact Bristol-Myers Squibb

Medical Disclaimer

NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.

The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.

Experienced a Side Effect?

Report to

👉
Yellowcard logo
(UK)
👉
Medwatch logo
(US)
NowPatient - Report Side Effects to Yellow Card or MedWatch